共 116 条
[1]
Chen Y(2020)Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma Int J Pharm 584 1050-1059
[2]
Du Q(2007)Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat Med 13 710-717
[3]
Zou Y(1979)Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 302-314
[4]
Apetoh L(1973)A clinicopathologic analysis of adriamycin cardiotoxicity Cancer 32 817-828
[5]
Ghiringhelli F(1987)Subcellular effects of adriamycin in the heart: a concise review J Mol Cell Cardiol 19 660-668
[6]
Tesniere A(1964)Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope J Mol Biol 8 1-9
[7]
Von Hoff DD(2013)Liposome: classification, preparation, and applications Nanoscale Res Lett 8 591325-785
[8]
Layard MW(2011)Liposome technology for industrial purposes J Drug Deliv 2011 751-120
[9]
Basa P(1996)Pharmacological-toxicological expert report CAELYXTM:(stealth® liposomal doxorubicin HCl) Hum Exp Toxicol 15 115-920
[10]
Lefrak EA(2001)Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer Crit Rev Oncol Hematol 37 903-21